Thus, we revealed the key role of the glycolysis regulator PFKFB3 in the development of DKD in rodent models and found that inhibiting PFKFB3 inhibited the synthesis of inflammatory cytokines, chemokines, and adhesion molecules. This evidence concerns the gene PFKFB3 and diabetic kidney disease.